Cargando…

Antibody-mediated targeting of viral vectors to the Fc receptor expressed on acute myeloid leukemia cells

Detalles Bibliográficos
Autores principales:	Würdinger, T, Verheije, M H, van der Aa, L M, Bosch, B J, de Haan, C A M, van Beusechem, V W, Gerritsen, W R, Rottier, P J M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2006
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099968/ https://www.ncbi.nlm.nih.gov/pubmed/17039233 http://dx.doi.org/10.1038/sj.leu.2404422

Ejemplares similares

Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibody
por: Würdinger, T, et al.
Publicado: (2005)

Vector induced skewing of antibody Fc-effector functions
por: Chung, A, et al.
Publicado: (2012)

Retargeting of Viruses to Generate Oncolytic Agents
por: Verheije, M. H., et al.
Publicado: (2012)

Adenoviral vector-mediated expression of a gene encoding secreted, EpCAM-targeted carboxylesterase-2 sensitises colon cancer spheroids to CPT-11
por: Oosterhoff, D, et al.
Publicado: (2005)

Coronavirus Cell Entry Occurs through the Endo-/Lysosomal Pathway in a Proteolysis-Dependent Manner
por: Burkard, Christine, et al.
Publicado: (2014)

Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection
por: Bournazos, Stylianos, et al.
Publicado: (2020)

Mouse Hepatitis Coronavirus RNA Replication Depends on GBF1-Mediated ARF1 Activation
por: Verheije, Monique H., et al.
Publicado: (2008)

SIRPαFc treatment targets human acute myeloid leukemia stem cells
por: Galkin, Oleksandr, et al.
Publicado: (2020)

Adaptation of novel H7N9 influenza A virus to human receptors
por: Dortmans, J. C. F. M., et al.
Publicado: (2013)

Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies
por: van der Horst, Hilma J., et al.
Publicado: (2020)

Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseases
por: Chan, Kuan Rong, et al.
Publicado: (2015)

Myeloid leukemia after hematotoxins.
por: Larson, R A, et al.
Publicado: (1996)

Enterocytes, fibroblasts and myeloid cells synergize in anti-bacterial and anti-viral pathways with IL22 as the central cytokine
por: Klooster, Jean Paul ten, et al.
Publicado: (2021)

WEE1 inhibition sensitizes osteosarcoma to radiotherapy
por: PosthumaDeBoer, Jantine, et al.
Publicado: (2011)

The influence of antibody engineering on Fc conformation and Fc receptor binding properties: Analysis of FcRn-binding engineered antibodies and an Fc fusion protein
por: Suzuki, Takuo, et al.
Publicado: (2021)

Viral gene delivery vectors: the next generation medicines for immune-related diseases
por: De Haan, Peter, et al.
Publicado: (2020)

Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemia
por: Parting, Oliver, et al.
Publicado: (2020)

Monoclonal antibodies and Fc fragments for treating solid tumors
por: Eisenbeis, Andrea M, et al.
Publicado: (2012)

Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection
por: Gunn, Bronwyn M., et al.
Publicado: (2021)

Detection of anti-Toxoplasma gondii antibodies in chronic myeloid leukemia and acute myeloid leukemia patients
por: Gharavi, Mohammad Javad, et al.
Publicado: (2017)

Myeloid Leukemias: A Glance at Middle Eastern Centers
por: Khaled, Safaa AA, et al.
Publicado: (2019)

Acute myeloid leukemia targets for bispecific antibodies
por: Hoseini, S S, et al.
Publicado: (2017)

Acute myeloid leukemia targets for bispecific antibodies
por: Hoseini, S S, et al.
Publicado: (2017)

FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils
por: Treffers, Louise W., et al.
Publicado: (2019)

Spike protein assembly into the coronavirion: exploring the limits of its sequence requirements
por: Bosch, Berend Jan, et al.
Publicado: (2005)

Polo-like kinase inhibitor volasertib marginally enhances the efficacy of the novel Fc-engineered anti-CD33 antibody BI 836858 in acute myeloid leukemia
por: Gopalakrishnan, Bhavani, et al.
Publicado: (2018)

Secreted and tumour targeted human carboxylesterase for activation of irinotecan
por: Oosterhoff, D, et al.
Publicado: (2002)

Promoting Fc-Fc interactions between anti-capsular antibodies provides strong immune protection against Streptococcus pneumoniae
por: Aguinagalde Salazar, Leire, et al.
Publicado: (2023)

Therapy-related Myeloid Neoplasms in Patients With Chronic Lymphocytic Leukemia Who Received FCR/FC as Frontline Therapy
por: Laribi, Kamel, et al.
Publicado: (2022)

Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody
por: van Elsas, Marit J., et al.
Publicado: (2022)

The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies
por: Gogesch, Patricia, et al.
Publicado: (2021)

Oncolytic adenovirus ORCA‐010 increases the type 1 T cell stimulatory capacity of melanoma‐conditioned dendritic cells
por: López González, M., et al.
Publicado: (2020)

Quantitative Assay of Mutated Nucleophosmin in Acute Myeloid Leukemia
por: Khaled, Safaa A.A., et al.
Publicado: (2019)

The neonatal Fc receptor is expressed by human lymphocytes
por: van Bilsen, K, et al.
Publicado: (2010)

Host Tissue and Glycan Binding Specificities of Avian Viral Attachment Proteins Using Novel Avian Tissue Microarrays
por: Ambepitiya Wickramasinghe, Iresha N., et al.
Publicado: (2015)

Fc gamma receptor IIa suppresses type I and III interferon production by human myeloid immune cells
por: Newling, Melissa, et al.
Publicado: (2018)

CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering
por: Oostindie, Simone C., et al.
Publicado: (2019)

Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections
por: Keeler, Shamus P., et al.
Publicado: (2021)

Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies
por: Demminger, Daniel E, et al.
Publicado: (2020)

Rational engineering of Fc/Fc receptor interactions to improve antibody potency
por: Doberstein, S, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_rf5t4i2cdp2q8gvjjmibqhu1op